<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01169389</url>
  </required_header>
  <id_info>
    <org_study_id>KM/10/2008/18</org_study_id>
    <nct_id>NCT01169389</nct_id>
  </id_info>
  <brief_title>Analgesic Control Following Knee Arthroscopy</brief_title>
  <official_title>Analgesic Control Following Knee Arthroscopy: Results of a Randomised , Double-blinded Trial Comparing a Hyaluronic Acid Supplement to Bupivacaine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orthopaedic Research and Innovation Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orthopaedic Research and Innovation Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the analgesic effects offered by bupivacaine and Durolane (a
      hyaluronic acid supplement) administered immediately following the completion of knee
      arthroscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is increasing evidence of the toxic effects of intraarticular administration of local
      anaesthetic. Hyaluronic acid supplementation given at the time of knee arthroscopy has not
      been fully evaluated as a possible alternative. We have studied the efficacy of a hyaluronic
      acid (HA) supplement (Durolane®) and a local anaesthetic (Bupivacaine) at providing early and
      short-term post-operative analgesic control following knee arthroscopy.Patients will be
      randomised to receive either 10mls of 0.5% Bupivacaine or 10mls of Durolane® into the joint
      immediately after completion of surgery. WOMAC and Tegner-Lysholm scores were obtained at
      baseline then at 1, 2, and 6-weeks post surgery. VAS pain scores were obtained at baseline; 1
      and 24-hours; and 1, 2 and 6 weeks following surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale pain score</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale pain score</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale pain score</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale pain score</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Knee</condition>
  <condition>Arthroscopy</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Durolane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraarticular injection</intervention_name>
    <description>Durolane, one vial</description>
    <arm_group_label>Durolane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intra-articular injection of 0.5% Bupivacaine</intervention_name>
    <arm_group_label>Bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  those undergoing knee arthroscopy for: diagnostic purposes, removal of loose bodies,
             articular cartilage debridement or, meniscectomy

          -  age over 18 years

        Exclusion Criteria:

          -  American Society of Anaesthesiologists (ASA) grade ≥3;

          -  arthroscopic assisted osteotomies;

          -  a history of two or more prior procedures on the ipsilateral knee;

          -  post-operative morbidities indirectly linked to the procedure (e.g. anaesthetic
             complications, DVT or PE);

          -  systemic steroid requirements;

          -  previous intra-articular anaesthetic or steroid injection within the last three
             months;

          -  intra-articular HA injection within the last nine months;

          -  intra-articular sepsis within the previous three months;

          -  prior history of knee arthroplasty, peri-articular fracture, ligamentous instability,
             inflammatory arthritis or a previous diagnosis of Complex Regional Pain Syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin J Mulhall, FRCSI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Research and Innovation Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sports Surgery Clinic</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2010</study_first_submitted>
  <study_first_submitted_qc>July 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2010</study_first_posted>
  <last_update_submitted>July 29, 2010</last_update_submitted>
  <last_update_submitted_qc>July 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kevin Mulhall</name_title>
    <organization>Orthopaedic Research and Innovation Foundation</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

